leisure time
explore
focus
-
The FDA must approve intranasal treatments for anaphylaxis
2025-10-02 05:19 -
Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc
2025-10-02 04:54 -
Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc
2025-10-02 04:48 -
Antibiotic resistance and the global rise in human conflict
2025-10-02 04:46 -
Readout Newsletter: Allogene's pivot, Illumina exec to lead Delfi
2025-10-02 04:15 -
A daunting task: navigating dual Medicare, Medicaid eligibility
2025-10-02 03:36